ruxolitinib,fedratinib
novartis,incyte,bms
['ruxolitinib', 'rux,(-crux),(-trux),(-deruxtecan)', 'fedra']
presentation from john mascarenhas, md: the use of fedratinib for myelofibrosis as a potential bridge to hematopoietic stem cell transplantation after ruxolitinib failure #ash2022 
Official account of The Tisch Cancer Institute @MountSinaiNYC. Committed to cancer prevention, detection, treatment & research. Appointments:  1-844-MD CANCER